These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 29016756)

  • 1. The electrocardiogram as a predictor of successful pharmacological cardioversion and progression of atrial fibrillation.
    Zeemering S; Lankveld TAR; Bonizzi P; Limantoro I; Bekkers SCAM; Crijns HJGM; Schotten U
    Europace; 2018 Jul; 20(7):e96-e104. PubMed ID: 29016756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial Fibrillation Complexity Parameters Derived From Surface ECGs Predict Procedural Outcome and Long-Term Follow-Up of Stepwise Catheter Ablation for Atrial Fibrillation.
    Lankveld T; Zeemering S; Scherr D; Kuklik P; Hoffmann BA; Willems S; Pieske B; Haïssaguerre M; Jaïs P; Crijns HJ; Schotten U
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003354. PubMed ID: 26823480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of ECG predictors of sinus rhythm maintenance after electrical cardioversion for persistent atrial fibrillation.
    Lankveld T; de Vos CB; Limantoro I; Zeemering S; Dudink E; Crijns HJ; Schotten U
    Heart Rhythm; 2016 May; 13(5):1020-1027. PubMed ID: 26776554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of sinus rhythm after electrical cardioversion of atrial fibrillation: results from a data mining project on the Flec-SL trial data set.
    Oto E; Okutucu S; Katircioglu-Öztürk D; Güvenir HA; Karaagaoglu E; Borggrefe M; Breithardt G; Goette A; Ravens U; Steinbeck G; Wegscheider K; Oto A; Kirchhof P
    Europace; 2017 Jun; 19(6):921-928. PubMed ID: 27377074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillation.
    Huang HD; Waks JW; Steinhaus DA; Zimetbaum P
    Heart Rhythm; 2016 Jul; 13(7):1410-7. PubMed ID: 26921760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive prediction of catheter ablation outcome in persistent atrial fibrillation by fibrillatory wave amplitude computation in multiple electrocardiogram leads.
    Zarzoso V; Latcu DG; Hidalgo-Muñoz AR; Meo M; Meste O; Popescu I; Saoudi N
    Arch Cardiovasc Dis; 2016 Dec; 109(12):679-688. PubMed ID: 27402153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of successful cardioversion with vernakalant in patients with recent-onset atrial fibrillation.
    Mochalina N; Juhlin T; Öhlin B; Carlson J; Holmqvist F; Platonov PG
    Ann Noninvasive Electrocardiol; 2015 Mar; 20(2):140-7. PubMed ID: 25040826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation.
    Hesselkilde EZ; Carstensen H; Haugaard MM; Carlson J; Pehrson S; Jespersen T; Buhl R; Platonov PG
    BMC Cardiovasc Disord; 2017 Dec; 17(1):289. PubMed ID: 29221440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation.
    Limantoro I; De Vos CB; Delhaas T; Marcos E; Blaauw Y; Weijs B; Tieleman RG; Pisters R; Schotten U; Van Gelder IC; Crijns HJ
    Heart Rhythm; 2014 Mar; 11(3):478-84. PubMed ID: 24321238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface ECG f Wave Analysis at Initial Onset of Paroxysmal and Persistent Atrial Fibrillation.
    Sharma P; Barrett TW; Ng J; Knoten C; Ferreira AJ; Goldberger JJ
    J Cardiovasc Electrophysiol; 2017 May; 28(5):498-503. PubMed ID: 28190278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal mechanisms and enhanced efficiency of atrial fibrillation cardioversion by pulmonary delivery of a novel flecainide formulation.
    Tessarolo Silva F; Pedreira GC; Medeiros SA; Bortolotto AL; Araujo Silva B; Hurrey M; Madhavapeddi P; Schuler C; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2020 Jan; 31(1):205-213. PubMed ID: 31749267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation.
    Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Allessie MA
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.
    Beatch GN; Mangal B
    BMC Cardiovasc Disord; 2016 May; 16():113. PubMed ID: 27233239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of good responders to rhythm control of paroxysmal and persistent atrial fibrillation by transthoracic and transesophageal echocardiography.
    Wang YC; Lin LC; Lin MS; Lai LP; Hwang JJ; Tseng YZ; Tseng CD; Lin JL
    Cardiology; 2005; 104(4):202-9. PubMed ID: 16155395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effectiveness and safety of antazoline-based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short-duration atrial fibrillation in the emergency department.
    Farkowski MM; Maciag A; Zurawska M; Kowalik I; Szwed H; Pytkowski M
    Cardiovasc Ther; 2018 Dec; 36(6):e12469. PubMed ID: 30281920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of antazoline in the rapid cardioversion of paroxysmal atrial fibrillation (the AnPAF Study).
    Maciag A; Farkowski MM; Chwyczko T; Beckowski M; Syska P; Kowalik I; Pytkowski M; Wozniak J; Dabrowski R; Szwed H
    Europace; 2017 Oct; 19(10):1637-1642. PubMed ID: 28339554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of atrial electromechanical delay for atrial fibrillation recurrence.
    Ari H; Ari S; Akkaya M; Aydin C; Emlek N; Sarigül OY; Çetinkaya S; Bozat T; Şentürk M; Karaağaç K; Melek M; Yilmaz M
    Cardiol J; 2013; 20(6):639-47. PubMed ID: 24338542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coefficient of Variation of P-Wave Duration Is a Novel Atrial Heterogeneity Index to Predict Recurrence of Atrial Fibrillation After Catheter Ablation.
    Nakatani Y; Sakamoto T; Mizumaki K; Nishida K; Kataoka N; Tsujino Y; Yamaguchi Y; Inoue H
    J Cardiovasc Electrophysiol; 2016 May; 27(5):542-8. PubMed ID: 26756553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.